股票 › RVMD
革命医药 RVMD
美股市值排名 #525
$192.28 +$14.63 (+8.24%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $194.38 +1.09%
开盘$184.87
昨收$177.65
当日区间$181.27 – $195.02
成交量4.50M
市值$41.59B
市盈率（TTM）–
股息率–
RVMD 相关新闻
匹配 Revolution Medicines 或代码 RVMD 的头条新闻，按最新排序。
- Stifel Maintains Revolution Medicines(RVMD.US) With Buy Rating, Raises Target Price to $230 正面
- Truist Financial Maintains Revolution Medicines(RVMD.US) With Buy Rating
- Analysts' Top Healthcare Picks: Revolution Medicines (RVMD), Fortrea Holdings Inc. (FTRE)
- Jefferies Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $270
- LifeSci Capital Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $315
- Brookline Capital Initiates Revolution Medicines(RVMD.US) With Buy Rating, Announces Target Price $318
- Goldman Sachs Initiates Revolution Medicines(RVMD.US) With Buy Rating, Announces Target Price $267
- BofA Securities Maintains Revolution Medicines(RVMD.US) With Buy Rating, Raises Target Price to $265 正面
- J.P. Morgan Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $246
- RBC Capital Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $251
- Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), ArriVent BioPharma, Inc. (AVBP) 正面
- Stifel Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $230
- Morgan Stanley Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $255
- Morgan Stanley Initiates Revolution Medicines(RVMD.US) With Buy Rating, Announces Target Price $255
- Needham Maintains Revolution Medicines(RVMD.US) With Buy Rating, Raises Target Price to $275 正面
暂无评论——快来第一个聊聊 RVMD。
登录后参与讨论。